Buscar
Mostrando ítems 1-10 de 50
The Place of protease inhibitors in antiretroviral treatment
(Brazilian Society of Infectious Diseases, 2009-10-01)
With the introduction of highly active antiretroviral therapy, a number of drugs have been developed. The best choice concerning which antiretroviral analogs to start is always under discussion, especially in the choice ...
HIV-1 drug resistance genotypic profiles in children with undetectable plasma viremia during antiretroviral therapy
(Brazilian Society of Infectious Diseases, 2011-02-01)
Treatment of HIV-1 infection with highly active antiretroviral therapy has led to sustained viral suppression in the plasma in a large number of children. However, studies have suggested that the integrated provirus in ...
O papel do exercício na era da terapia anti-retroviral fortemente ativaThe role of exercise in the era of highly active an tiretroviral therapy
(Universidade Católica de Brasília, 2014)
Occurrence of pneumocystis pneumonia in HIV-infected patients and the interference of the highly active antiretroviral therapy
(Universidade Estadual Paulista (Unesp), Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP), 2008-01-01)
From the beginning of the AIDS epidemic, pneumocystis pneumonia ( PCP) has been distinguished as one of the most frequent opportunistic diseases with high morbid-mortality. As from 1996, the advent of the highly active ...
The success of endosseous implants in human immunodeficiency virus-positive patients receiving antiretroviral therapy A pilot study
(Amer Dental Assoc, 2011-09-01)
Background. In a pilot study, the authors aimed to determine the success rate of dental implants placed in patients who were positive for human immunodeficiency virus (HIV) and were receiving different regimens of highly ...
Resolution of microsporidial keratoconjunctivitis in an AIDS patient treated with highly active antiretroviral therapy
(Elsevier B.V., 2001-03-01)
PURPOSE: To report the outcome of microsporidial keratoconjunctivitis in a patient with acquired immunodeficiency syndrome (AIDS) after highly active antiretroviral therapy without any specific treatment for microsporidi ...
Characterization of virologic failure after an initially successful 48-week course of antiretroviral therapy in HIV/AIDS outpatients treated in Santos, Brazil
(Brazilian Society of Infectious Diseases, 2008-06-01)
We characterized the virologic failure after an initially successful 48-week course of antiretroviral therapy among HIV/AIDS patients in a retrospective cohort study involving patients from Santos, Brazil. Patients with ...
Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status
(Walter de Gruyter & Co, 2004-01-01)
HIV infection is associated with disturbances in lipid metabolism due to a host's response mechanism and the current antiretroviral therapy. The pathological appearance and progression of atherosclerosis is dependent on ...
Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption
(Elsevier B.V., 2006-10-10)
We analyzed gp120V3 HIV-1 env region genetic diversity of 27 patients failing antiretrovirals and subjected to 12-week structured treatment interruption (STI). Based on heteroduplex mobility assays, eight patients presented ...
Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy
(2006-06-01)
The use of highly active antiretroviral therapy (HAART) in HIV-infected patients has been associated with the development of risk factors for cardiovascular diseases (CD) including dyslipidemia and insulin resistance, ...